Yüklüyor......
A Bayesian Dose-finding Design for Phase I/II Clinical Trials with Non-ignorable Dropouts
Phase I/II trials utilize both toxicity and efficacy data to achieve efficient dose finding. However, due to the requirement of assessing efficacy outcome, which often takes a long period of time to be evaluated, the duration of phase I/II trials is often longer than that of the conventional dose-fi...
Kaydedildi:
| Yayımlandı: | Stat Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4390488/ https://ncbi.nlm.nih.gov/pubmed/25626676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6443 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|